Aptevo Therapeutics (APVO) Earnings Date & Reports

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

APVO is expected to report earnings to fall 96.35% to -43 cents per share on May 09

Aptevo Therapeutics APVO Stock Earnings Reports

Q1'24

Est.

$-0.44

Q4'23

Missed

by $11.52

Q3'23

Missed

by $21.36

Q2'23

Missed

by $53.00

Q1'23

Beat

by $1.61

The last earnings report on March 06 showed earnings per share of -1193 cents, missing the estimate of -40 cents. With 28.70M shares outstanding, the current market capitalization sits at 2.01M.

View a ticker or compare two or three

Compare

APVO